Company Filing History:
Years Active: 2017
Title: Hae-Sun Kim: Innovator in Histone Lysine Demethylase Modulation
Introduction
Hae-Sun Kim is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of histone lysine demethylases (KDMs). His innovative work has the potential to impact cancer treatment and other diseases related to KDM dysregulation.
Latest Patents
Hae-Sun Kim holds a patent for "Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)." This invention provides a compound of Formula (I) that is capable of modulating the activity of KDMs. The patent outlines pharmaceutical compositions, methods for preparing these compounds, and their use as medicaments. The compound acts as a KDM inhibitor with marked potency, showcasing outstanding potential for pharmaceutical intervention in cancer and other related diseases.
Career Highlights
Hae-Sun Kim is associated with Dong-a St Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the pursuit of effective therapeutic solutions.
Collaborations
Hae-Sun Kim collaborates with esteemed colleagues, including Myeong-seop Kim and Taesun Park. Their combined expertise contributes to the advancement of their research initiatives.
Conclusion
Hae-Sun Kim's contributions to the field of pharmaceutical sciences, particularly through his patent on KDM modulation, highlight his role as an influential inventor. His work holds promise for future medical advancements in treating diseases associated with KDM dysregulation.